HOLOCENE ADVISORS, LP – Revance Therapeutics, Inc. Transaction History
HOLOCENE ADVISORS, LP portfolio value:
$28.78M
portfolio value
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 1.06M shares | 28.78M | $27 | 1.06M |